Fluvoxamine

Obsessive-Compulsive Disorder

Fluvoxamine is primarily prescribed to treat obsessive-compulsive disorder (OCD). This condition involves persistent, unwanted thoughts (obsessions) and the urge to perform repetitive tasks or rituals (compulsions). The medication helps reduce the frequency and intensity of these symptoms, which can otherwise significantly interfere with a person's daily life and social functioning.

Social Anxiety Disorder

This medication is also used to treat social anxiety disorder, also known as social phobia. This condition is characterized by an intense and persistent fear of being watched or judged by others in social situations. It can help manage the overwhelming anxiety that occurs during social interactions or performance situations.

General Use

Fluvoxamine belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by increasing the levels of serotonin, a natural chemical in the brain that helps maintain mental balance. By restoring this balance, the medication can help improve mood, sleep, and energy levels while decreasing anxiety and unwanted thoughts.

How Fluvoxamine Works

Fluvoxamine belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). It is primarily used to help manage the symptoms of obsessive-compulsive disorder (OCD) by affecting the balance of chemicals in the brain.

The brain uses various chemical messengers, called neurotransmitters, to send signals between nerve cells. One of these messengers is serotonin, which plays a key role in regulating mood, anxiety, and repetitive behaviors. In many people with OCD, the balance of serotonin may be disrupted.

Fluvoxamine works through the following process:

• Release: Nerve cells release serotonin to pass a message to the next cell.
• Reuptake Inhibition: Normally, the brain quickly reabsorbs serotonin after it has performed its task. Fluvoxamine blocks (inhibits) this reabsorption process.
• Increased Availability: By slowing down the reuptake, the medication allows more serotonin to stay in the space between nerve cells for a longer period.

This increased availability of serotonin improves the transmission of messages between neurons, which helps stabilize brain activity and reduce the frequency and intensity of obsessive thoughts and compulsive behaviors.

Common Side Effects

Fluvoxamine may cause side effects that are usually mild and may go away as your body adjusts to the medicine. These include:

• Nausea, vomiting, gas, or stomach pain
• Diarrhea or constipation
• Dry mouth
• Drowsiness, dizziness, or feeling weak
• Nervousness, anxiety, or trouble sleeping
• Loss of appetite or weight changes
• Sweating or shaking
• Changes in sexual drive or performance
• Sore throat or muscle pain

Serious Side Effects

Some side effects can be serious. You should contact your doctor immediately if you experience:

• Signs of an allergic reaction like rash, hives, or swelling of the face, lips, or tongue
• Seizures
• Unusual bleeding or bruising
• Hallucinations or extreme confusion
• Fast, pounding, or irregular heartbeat
• Low sodium levels, which can cause headache, confusion, memory problems, or weakness

Serotonin Syndrome

This is a rare but life-threatening condition that requires immediate medical attention. Seek emergency care if you have symptoms such as:

• Extreme agitation or restlessness
• Loss of coordination or muscle twitching
• Muscle stiffness
• Shivering or heavy sweating
• Fever
• Severe nausea, vomiting, or diarrhea

Suicidal Thoughts and Behaviors

Fluvoxamine carries a boxed warning because antidepressants can increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24. It is important for caregivers and families to monitor for worsening depression, sudden changes in behavior, or the emergence of suicidal thoughts, especially during the first few months of treatment or when the dose is changed.

Serotonin Syndrome

A potentially life-threatening condition called serotonin syndrome may occur, particularly when fluvoxamine is used with other drugs that affect serotonin. Symptoms can include agitation, hallucinations, fast heartbeat, dizziness, flushing, muscle tremors, or gastrointestinal issues. If these symptoms occur, medical attention is typically required immediately.

Contraindications

Fluvoxamine should not be used in combination with certain medications due to the risk of severe or fatal interactions. These include:

• Monoamine oxidase inhibitors (MAOIs) used within the last 14 days.
• Thioridazine or pimozide.
• Alosetron, tizanidine, or ramelteon.

Bleeding Risk

Fluvoxamine may increase the risk of bleeding, especially when taken with aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or blood thinners such as warfarin. This can result in bruising, nosebleeds, or more serious internal bleeding.

Additional Precautions

• Mania and Bipolar Disorder: Fluvoxamine may trigger manic or hypomanic episodes. Screening for bipolar disorder is often recommended before starting treatment.
• Seizures: The medication should be used with caution in individuals with a history of seizure disorders.
• Hyponatremia: Low blood sodium levels can occur, particularly in elderly patients or those taking diuretics.
• Angle-Closure Glaucoma: Fluvoxamine may trigger an acute glaucoma attack in people with anatomically narrow eye angles who have not had a preventative procedure.
• Discontinuation: Stopping fluvoxamine abruptly can lead to withdrawal symptoms such as dizziness, anxiety, headache, and sleep disturbances. A gradual reduction in dose is usually recommended.

Pregnancy

The use of fluvoxamine during pregnancy involves weighing the benefits of treating obsessive-compulsive disorder against potential risks to the fetus. Research suggests that infants exposed to selective serotonin reuptake inhibitors (SSRIs) like fluvoxamine late in the third trimester may experience complications at birth that require medical intervention or extended hospital stays.

Potential complications in newborns may include:

• Respiratory distress or difficulty breathing
• Seizures
• Temperature instability
• Feeding difficulties and vomiting
• Tremors, jitteriness, or irritability
• Constant crying

There is also a risk of persistent pulmonary hypertension of the newborn (PPHN), a serious condition affecting the infant's lungs. However, untreated mental health conditions during pregnancy also carry risks. It is important to consult a healthcare provider before starting or stopping this medication while pregnant.

Breastfeeding

Fluvoxamine is known to pass into human breast milk. Because the medication is excreted in milk, there is a potential for side effects in the nursing infant. A decision to continue breastfeeding while taking fluvoxamine should be made in consultation with a healthcare professional, considering the importance of the drug to the mother and the potential impact on the child.

Available Forms

Fluvoxamine is provided in the following oral formulations:

• Immediate-release tablets: These are standard tablets for oral administration.
• Extended-release capsules: These are long-acting capsules designed to release the medication gradually into the body.

FDA Approval and Indications

Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1994. It is specifically indicated for the treatment of obsessive-compulsive disorder (OCD) in adults and pediatric patients between the ages of 8 and 17. While it belongs to the SSRI class of medications, its primary labeled indication in the United States is for OCD rather than major depressive disorder.

Boxed Warning

The FDA requires a boxed warning for fluvoxamine, which is the highest level of safety alert. This warning highlights an increased risk of suicidal thinking and behavior in children, adolescents, and young adults (up to age 24) during the initial months of treatment or when the dose is changed. Healthcare providers are advised to monitor patients of all ages closely for clinical worsening, suicidality, or unusual changes in behavior.

Regulatory Requirements

• Medication Guide: Pharmacies are required to provide an FDA-approved Medication Guide to patients each time fluvoxamine is dispensed. This guide outlines the risks of suicidal thoughts and other serious side effects.
• Controlled Substance Status: Fluvoxamine is not a controlled substance under the Controlled Substances Act. It is available only by prescription.

Safety Communications

The FDA has issued safety communications regarding the risk of serotonin syndrome when SSRIs like fluvoxamine are used in combination with other serotonergic medications, such as triptans or MAOIs. Additionally, regulatory information notes potential risks during pregnancy, including the risk of persistent pulmonary hypertension in newborns exposed to SSRIs late in the third trimester.

Withdrawal Symptoms

If you stop taking fluvoxamine abruptly, you may experience a range of physical and psychological symptoms. These effects are often referred to as discontinuation syndrome. Common symptoms include:

• Dizziness and lightheadedness
• Irritability, agitation, or anxiety
• Confusion or difficulty concentrating
• Headaches and extreme tiredness
• Nausea and increased sweating
• Difficulty falling asleep or staying asleep

Some people also report sensory disturbances, such as numbness, tingling, or sensations that feel like electric shocks in the hands or feet.

How to Stop Safely

To prevent or minimize withdrawal symptoms, healthcare providers typically recommend gradually reducing the dose over a period of weeks or months rather than stopping all at once. If symptoms become severe while tapering, your doctor may adjust the schedule to a slower pace. Always consult your healthcare provider before making any changes to how you take this medication.